The lawsuit alleges infringement of Chemours’ patents covering HFO-1234yf product compositions and usage in automotive air conditioning and stationary refrigeration applications in Japan.
“Innovation and product development are at the core of who we are at Chemours,” said Diego Boeri, vice president of Chemours Fluorochemicals. “By protecting our innovation, we are also ensuring our customers have access to the safe and high-quality refrigerants that they have come to rely on from Chemours and the Opteon brand,” he added.